EE81 Cost-Effectiveness of CDK 4/6I for the Treatment of Postmenopausal Patients With Advanced Breast Cancer HR-Positive, HER2-Negative From the Point of View of the Payer of the Public Health System in Panama
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.353
https://www.valueinhealthjournal.com/article/S1098-3015(23)03483-6/fulltext
Title :
EE81 Cost-Effectiveness of CDK 4/6I for the Treatment of Postmenopausal Patients With Advanced Breast Cancer HR-Positive, HER2-Negative From the Point of View of the Payer of the Public Health System in Panama
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)03483-6&doi=10.1016/j.jval.2023.09.353
First page :
Section Title :
Open access? :
No
Section Order :
12378